We used epidemiological data from 21195 patients with cancer and 180407 matched controls, including in-depth analyses in 216 cancer patients, to discover clinical and molecular determinants that predispose cancer patients to breakthrough infections. Patients with B cell malignancies, with differential expression of CD24, CDK14 and PLEKHG1, were most susceptible to breakthrough infections, suggesting that these patients may require more booster immunisations to ameliorate cellular responses and immune protection against COVID-19.
Cancer type and gene signatures associated with breakthrough infections following COVID-19 mRNA vaccination
COVID-19 mRNA疫苗接种后突破性感染相关的癌症类型和基因特征
阅读：1
作者：Youjia Zhong # ,Jiaqi Li # ,Ainsley Ryan Yan Bin Lee # ,Janice Yu Jin Tan # ,Carina Jing Xuan Tay ,Clara Wt Koh ,Ethan Yong Tzi Seow ,Wee Chee Yap ,Shi Yin Wong ,Chun En Yau ,Chen Ee Low ,Kelvin Bryan Tan ,Barnaby Edward Young ,Yan Su ,Arun George Devasia ,Perumal Dharuman ,Alexander Lezhava ,Rahul Pandey ,Panneer Selvi Govindaraju ,Sidney Yee ,Ruifen Weng ,Candy Khoo ,Shaun Shi Yan Tan ,Matilda Lee ,Joline Lim ,Esther Chan ,Carol Lf Ho ,Louis Yi Ann Chai ,Chee Wah Tan ,Soo Chin Lee ,Kuan Rong Chan ,Raghav Sundar
| 期刊： | NPJ Vaccines | 影响因子： | 6.900 |
| 时间： | 2025 | 起止号： | 2025 May 9;10(1):90. |
| doi： | 10.1038/s41541-025-01141-w | 研究方向： | 肿瘤 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用；引用内容仅为补充信息，不代表本站立场。
2、若认为本页面引用内容涉及侵权，请及时与本站联系，我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容，需注明“来源：[生知库]”并获得授权；使用引用内容的，需自行联系原作者获得许可。
4、投稿及合作请联系：info@biocloudy.com。